» Articles » PMID: 39339380

Thermo-Responsive Hydrogel Based on Lung Decellularized Extracellular Matrix for 3D Culture Model to Enhance Cancer Stem Cell Characteristics

Overview
Journal Molecules
Publisher MDPI
Specialty Biology
Date 2024 Sep 28
PMID 39339380
Authors
Affiliations
Soon will be listed here.
Abstract

Cancer stem cells (CSCs) are most likely the main cause of lung cancer formation, metastasis, drug resistance, and genetic heterogeneity. Three-dimensional (3D) ex vivo cell culture models can facilitate stemness improvement and CSC enrichment. Considering the critical role of extracellular matrix (ECM) on CSC properties, the present study developed a thermo-responsive hydrogel using the porcine decellularized lung for 3D cell culture, and the cell-laden hydrogel culturing model was used to explore the CSC characteristics and potential utilization in CSC-specific drug evaluation. Results showed that the lung dECM hydrogel (LEH) was composed of the main ECM components and displayed excellent cellular compatibility. In addition, lung cancer cells 3D cultured in LEH displayed the overexpression of metastasis-related genes and enhanced migration properties, as compared with those in two-dimensional (2D) conditions. Notably, the CSC features, including the expression level of stemness-associated genes, colony formation capability, drug resistance, and the proportion of cancer stem-like cells (CD133), were also enhanced in 3D cells. Furthermore, the attenuation effect of epigallocatechin gallate (EGCG) on CSC properties in the 3D model was observed, confirming the potential practicability of the 3D culture on CSC-targeted drug screening. Overall, our results suggest that the fabricated LEH is an effective and facile platform for 3D cell culture and CSC-specific drug evaluation.

Citing Articles

Oncogenic Mutations and the Tumor Microenvironment: Drivers of Non-Small Cell Lung Cancer Progression.

Mitrakas A, Kakouratos C, Lamprou I, Xanthopoulou E, Koukourakis M Cancers (Basel). 2025; 17(5).

PMID: 40075700 PMC: 11899603. DOI: 10.3390/cancers17050853.

References
1.
Clara J, Monge C, Yang Y, Takebe N . Targeting signalling pathways and the immune microenvironment of cancer stem cells - a clinical update. Nat Rev Clin Oncol. 2019; 17(4):204-232. DOI: 10.1038/s41571-019-0293-2. View

2.
Jiang P, Xu C, Zhang P, Ren J, Mageed F, Wu X . Epigallocatechin‑3‑gallate inhibits self‑renewal ability of lung cancer stem‑like cells through inhibition of CLOCK. Int J Mol Med. 2020; 46(6):2216-2224. PMC: 7595654. DOI: 10.3892/ijmm.2020.4758. View

3.
Chu M, Zheng C, Chen C, Song G, Hu X, Wang Z . Targeting cancer stem cells by nutraceuticals for cancer therapy. Semin Cancer Biol. 2021; 85:234-245. DOI: 10.1016/j.semcancer.2021.07.008. View

4.
Condello S, Sima L, Ivan C, Cardenas H, Schiltz G, Mishra R . Tissue Tranglutaminase Regulates Interactions between Ovarian Cancer Stem Cells and the Tumor Niche. Cancer Res. 2018; 78(11):2990-3001. PMC: 5984683. DOI: 10.1158/0008-5472.CAN-17-2319. View

5.
Iram S, Rahman S, Ali S, Kim J . Tetranectin targeting by epigallocatechin gallate suppresses colon cancer cell proliferation. Int J Biol Macromol. 2022; 209(Pt A):211-219. DOI: 10.1016/j.ijbiomac.2022.03.160. View